title: [Methylphenidate and secondary Raynaud's phenomenon].
abstract: Raynaud's phenomenon is a clinical disease characterized by episodic attacks of vasoconstriction of the arteries and arterioles of the extremities such as fingers and toes, sometimes the ears and nose, in response to cold or emotional stimuli. A classic attack is the pallor of the distal extremity, followed by cyanosis and redness, accompanied by paresthesia, usually as heat. When it occurs without apparent cause is called primary Raynaud's phenomenon. When associated with other disease, is called secondary Raynaud's phenomenon. The secondary table is associated with increased frequency of rheumatic diseases of collagen. They can also present certain drugs that cause vasoconstriction, such as ergotamine, beta-adrenergic antagonists, contraception and sympathomimetic drugs. Regarding the latter, we present a case of Raynaud's phenomenon secondary to methylphenidate in a 14 years.
authors.affiliation: Medicina de Familia y Comunitaria, Centro de Salud de Padrón, Gerencia de Gestión Integrada de Santiago de Compostela, Servicio Gallego de Salud, España.
authors.forename: M
authors.initials: M
authors.lastname: Iglesias Otero
authors.forename: M
authors.initials: M
authors.lastname: Portela Romero
authors.forename: R
authors.initials: R
authors.lastname: Bugarín González
authors.forename: M A
authors.initials: MA
authors.lastname: Ventura Victoria
mesh_terms: D000293:Adolescent; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects*; D011928:Raynaud Disease / Q000139:chemically induced*
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate
keywords: Fenómeno de Raynaud primario; Fenómeno de Raynaud secundario; Methylphenidate; Metilfenidato; Primary Raynaud's phenomenon; Secundary Raynaud's phenomenon